A detailed history of Monimus Capital Management, LP transactions in Codexis, Inc. stock. As of the latest transaction made, Monimus Capital Management, LP holds 71,050 shares of CDXS stock, worth $292,726. This represents 0.32% of its overall portfolio holdings.

Number of Shares
71,050
Holding current value
$292,726
% of portfolio
0.32%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$2.91 - $5.81 $206,755 - $412,800
71,050 New
71,050 $339 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $270M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Monimus Capital Management, LP Portfolio

Follow Monimus Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monimus Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Monimus Capital Management, LP with notifications on news.